Advanced searches left 3/3

Neurotrophic Keratitis - Europe PMC

Summarized by Plex Scholar
Last Updated: 16 September 2022

* If you want to update the article please login/register

Bromfenac-induced neurotrophic keratitis in a corneal graft.

On a previous segment review on a routine follow-up visit, an epithelial defect with heaped up margins was identified eight months after transplantation. The patient was mistakenly using bromfenac drops in place of brimonidine tartrate for the past month, according to a questionnaire. In the case of PK diagnosis of viral keratitis caused by topical bromfenac use, a diagnosis of neurotrophic keratitis was made. Topical steroid drops were held off until the epithelial defect was healed.

Source link: https://europepmc.org/article/MED/35817488


Topical human recombinant nerve growth factor for stage 1 Neurotrophic Keratitis: Retrospective case series of cenegermin treatment.

Objectives: To report on the management and success of treating patients with stage I Neurotrophic Keratitis (stage I Neurotrophic Keratitis) with an 8-week course in topical recombinant human growth factor. Preexisting thyroid disease was present in the majority of patients. BCVA's three patients had dramatic rises in quality of life, while one patient had no change in their pre-treatment visual acuity. The four patients' symptoms were also reported reduced photophobia and improvements in their quality of life, according to three of them. For all four patients, this case series provides real-world evidence of the safety and effectiveness of cen. . . . min treatment of stage I NK.

Source link: https://europepmc.org/article/MED/35938145

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions